June 15 (Reuters) - Alexza Pharmaceuticals Inc:
* Announces agreement to acquire Symphony Allegro, including all rights to
AZ-004, AZ-104 and AZ-002
* Says will issue Symphony Capital 10 million shares of its common stock at
$2.26 per share
* Says will cancel Symphony's outstanding 2 million shares warrant for Alexza
common stock
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces agreement to acquire Symphony Allegro, including all rights to
AZ-004, AZ-104 and AZ-002
* Says will issue Symphony Capital 10 million shares of its common stock at
$2.26 per share
* Says will cancel Symphony's outstanding 2 million shares warrant for Alexza
common stock
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.